Ftag of the Week – F605 Right to be Free from Chemical Restraints (Pt. 3)

F605 Part 3 reviews CMS guidance related to dose, duration, and gradual dose reduction (GDR) for psychotropic medications. This post outlines key definitions from Appendix PP and explains CMS expectations for ensuring medications are used at the lowest effective dose for the shortest appropriate duration. It also discusses the regulatory requirement for GDRs, including CMS’s emphasis on modest, incremental reductions over adequate timeframes to monitor for symptom recurrence and minimize withdrawal effects. The importance of clear, comprehensive documentation is highlighted, along with practical considerations for demonstrating compliance during survey.